4.4 Article

An investigation of heterochromatin domains on the fourth chromosome of Drosophila melanogaster

Journal

GENETICS
Volume 178, Issue 3, Pages 1177-1191

Publisher

GENETICS SOCIETY AMERICA
DOI: 10.1534/genetics.107.081828

Keywords

-

Funding

  1. NIGMS NIH HHS [GM-31532] Funding Source: Medline

Ask authors/readers for more resources

The banded portion of Drosophila melanogaster chromosome 4 exhibits euchromatic and heterochromatic characteristics. Reminiscent of heterochromatin, it contains a high percentage of repetitive,e elements, does not undergo recombination, and exhibits high levels of HP1 and histone-3 lysine-9 dimethylation. However, in the distal 1.2 Mb, the gene density is typical of euchromatin, and this region is polytene in salivary gland nuclei. Using P-element reporters carrying a copy of hsp70-while, alternative chromatin packaging domains can be distinguished by the eye color phenotype. Mapping studies identified the repetitive element 1360 as a candidate for heterochromatin targeting in the fourth chromosome Hcf region. We report here two new screens rising this reporter to look For additional heterochromatin target sites. We confirm that reporter elements within 10 kb of 1360 are usually packaged as heterochromatin; however, heterochromatin packaging occurs in the sv region in the absence of 1360. Analyses of the sequences adjacent to P-element reporters show no simple association between specific repeated elements and transgene expression phenotype on a whole chromosome level. The data require that heterochromatin formation as a whole depends on a more complex pattern of sequence organization rather than the presence of a single sequence element.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Characterization of diverse homoserine lactone synthases in Escherichia coli

Rene Daer, Cassandra M. Barrett, Ernesto Luna Melendez, Jiaqi Wu, Stefan J. Tekel, Jimmy Xu, Brady Dennison, Ryan Muller, Karmella A. Haynes

PLOS ONE (2018)

Article Biochemical Research Methods

G-OnRamp: a Galaxy-based platform for collaborative annotation of eukaryotic genomes

Yating Liu, Luke Sargent, Wilson Leung, Sarah C. R. Elgin, Jeremy Goecks

BIOINFORMATICS (2019)

Article Biotechnology & Applied Microbiology

Engineered Orthogonal Quorum Sensing Systems for Synthetic Gene Regulation in Escherichia coil

Stefan J. Tekel, Christina L. Smith, Brianna Lopez, Amber Mani, Christopher Connot, Xylaan Livingstone, Karmella A. Haynes

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)

Editorial Material Biochemistry & Molecular Biology

Chromatin engineering offers an opportunity to advance epigenetic cancer therapy

Natecia L. Baskin, Karmella A. Haynes

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Components from the Human c-myb Transcriptional Regulation System Reactivate Epigenetically Repressed Transgenes

Cassandra M. Barrett, Reilly McCracken, Jacob Elmer, Karmella A. Haynes

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Editorial Material Biochemistry & Molecular Biology

Fund Black scientists Comment

Kelly R. Stevens, Kristyn S. Masters, P. I. Imoukhuede, Karmella A. Haynes, Lori A. Setton, Elizabeth Cosgriff-Hernandez, Muyinatu A. Lediju Bell, Padmini Rangamani, Shelly E. Sakiyama-Elbert, Stacey D. Finley, Rebecca K. Willits, Abigail N. Koppes, Naomi C. Chesler, Karen L. Christman, Josephine B. Allen, Joyce Y. Wong, Hana El-Samad, Tejal A. Desai, Omolola Eniola-Adefeso

Summary: The racial funding disparity by NIH is identified as a significant barrier to success for Black faculty members, prompting a collective effort to address and dismantle it.
Editorial Material Biochemistry & Molecular Biology

How Has the COVID-19 Pandemic Changed How You Will Approach Research and Lab Work in the Future?

Karmella Haynes, Christopher Yau, Andrea Bild, Ashley Laughney, Leonardo Morsut, Xia Yang, Judith Zaugg, Patrick Hsu, Vera Pancaldi, Srividya Iyer-Biswas

CELL SYSTEMS (2020)

Article Oncology

Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target

Cara E. Shields, Sindhu Potlapalli, Selma M. Cuya-Smith, Sarah K. Chappell, Dongdong Chen, Daniel Martinez, Jennifer Pogoriler, Komal S. Rathi, Shiv A. Patel, Kristianne M. Oristian, Corinne M. Linardic, John M. Maris, Karmella A. Haynes, Robert W. Schnepp

Summary: Rhabdomyosarcoma (RMS) is an aggressive pediatric soft tissue sarcoma with two main subtypes, alveolar rhabdomyosarcoma (ARMS) and embryonal rhabdomyosarcoma. There are no targeted therapies for ARMS, but recent studies have shown a potential cooperation between epigenetic proteins and PAX3-FOXO1 fusion, suggesting epigenetic proteins as targets in ARMS. In this study, BMI1 was identified as a potential therapeutic vulnerability in ARMS, with inhibition activating the Hippo pathway and reducing tumor growth.

MOLECULAR ONCOLOGY (2021)

Article Chemistry, Physical

The living interface between synthetic biology and biomaterial design

Allen P. Liu, Eric A. Appel, Paul D. Ashby, Brendon M. Baker, Elisa Franco, Luo Gu, Karmella Haynes, Neel S. Joshi, April M. Kloxin, Paul H. J. Kouwer, Jeetain Mittal, Leonardo Morsut, Vincent Noireaux, Sapun Parekh, Rebecca Schulman, Sindy K. Y. Tang, Megan T. Valentine, Sebastian L. Vega, Wilfried Weber, Nicholas Stephanopoulos, Ovijit Chaudhuri

Summary: Recent advancements in synthetic biology and biomaterials have provided exciting tools for creating new materials and extending the application of synthetic biology. Despite their transformative potential, these fields have mostly progressed separately. This Perspective reviews recent key advances and presents a roadmap for collaboration between the two communities, emphasizing the near-term applications in developing hierarchically structured biomaterials.

NATURE MATERIALS (2022)

Review Biochemistry & Molecular Biology

Beyond the marks: reader-effectors as drivers of epigenetics and chromatin engineering

Kierra A. Franklin, Cara E. Shields, Karmella A. Haynes

Summary: This article discusses the regulation of gene expression by chromatin and its associated proteins and enzymes. Recent studies have shown that reader-effectors play a key role in driving chromatin-mediated processes, although our understanding of these proteins is still limited. By integrating proteomics, epigenomics, and synthetic biology, further insights into the activity of reader-effectors can be gained.

TRENDS IN BIOCHEMICAL SCIENCES (2022)

Article Engineering, Biomedical

Differential Epigenetic Effects of BMI Inhibitor PTC-028 on Fusion-Positive Rhabdomyosarcoma Cell Lines from Distinct Metastatic Sites

Cara E. Shields, Robert W. Schnepp, Karmella A. Haynes

Summary: This study aimed to investigate the role of BMI1 as a therapeutic target in FP-RMS and identify gene expression changes associated with the inhibition of BMI1. The results showed that inhibition of BMI1 led to downregulation of cell cycle progression, DNA damage response, and cholesterol biosynthesis pathways in FP-RMS cell lines. It also identified potential kinases that are upregulated in response to BMI1 inhibition. These findings suggest that targeting BMI1 could be an effective therapy for FP-RMS.

REGENERATIVE ENGINEERING AND TRANSLATIONAL MEDICINE (2022)

Article Multidisciplinary Sciences

B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12

Rae Hunter, Kathleen J. Imbach, Chengjing Zhou, Jodi Dougan, Jamie A. G. Hamilton, Kevin Z. Chen, Priscilla Do, Ashley Townsel, Greg Gibson, Erik C. Dreaden, Edmund K. Waller, Karmella A. Haynes, Curtis J. Henry, Christopher C. Porter

Summary: This study identified immune suppression mechanisms in B-cell acute lymphoblastic leukemia (B-ALL) and explored strategies to overcome them. Differential cytokine expression and genes associated with immune exhaustion were observed in B-ALL patients with measurable residual disease. Leukemia cells were found to suppress T-cell function, and a compromised tumor immune microenvironment was observed in a mouse model of B-ALL. However, treatment with recombinant IL-12 (rIL-12) restored the immune microenvironment, increased the number of T-cells and dendritic cells, and reduced the expression of exhaustion-related genes. Additionally, combining IL-12 and blinatumomab treatments enhanced the cytolytic capacity of T-cells. These findings suggest that rIL-12 treatment could be therapeutically beneficial in B-ALL.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

Adipocyte-mediated epigenomic instability in human T-ALL cells is cytotoxic and phenocopied by epigenetic-modifying drugs

Miyoung Lee, Delaney K. K. Geitgey, Jamie A. G. Hamilton, Jeremy M. M. Boss, Christopher D. D. Scharer, Jennifer M. M. Spangle, Karmella A. A. Haynes, Curtis J. J. Henry

Summary: The relationship between obesity and T-ALL development is inverse, with obesity inducing cell death in T-ALL cells through epigenetic modifications. Epigenetic modifying drugs may be a potential treatment option for T-ALL.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Engineering, Biomedical

Site-directed targeting of transcriptional activation-associated proteins to repressed chromatin restores CRISPR activity

Rene Daer, Fatima Hamna, Cassandra M. Barrett, Karmella A. Haynes

APL BIOENGINEERING (2020)

No Data Available